First experience of COVID-19 screening of health-care workers in England E Hunter, DA Price, E Murphy, IS van der Loeff, KF Baker, D Lendrem, ... The Lancet 395 (10234), e77-e78, 2020 | 376 | 2020 |
Predation risk and vigilance in the blue tit (Parus caeruleus) DW Lendrem Behavioral Ecology and Sociobiology 14, 9-13, 1983 | 183 | 1983 |
Health-related utility values of patients with primary Sjögren's syndrome and its predictors D Lendrem, S Mitchell, P McMeekin, S Bowman, E Price, CT Pease, ... Annals of the rheumatic diseases 73 (7), 1362-1368, 2014 | 127 | 2014 |
Gain‐of‐function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC) J Zheng, FL van de Veerdonk, KL Crossland, SP Smeekens, CM Chan, ... European journal of immunology 45 (10), 2834-2846, 2015 | 123 | 2015 |
Vigilance and scanning patterns in birds A Hart, DW Lendrem Animal Behaviour 32 (4), 1216-1224, 1984 | 121 | 1984 |
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity ILA Bodewes, S Al-Ali, CG van Helden-Meeuwsen, NI Maria, J Tarn, ... Rheumatology 57 (5), 921-930, 2018 | 116 | 2018 |
Sleeping and vigilance in birds. I. Field observations of the mallard (Anas platyrhynchos) DW Lendrem Animal Behaviour 31 (2), 532-538, 1983 | 116 | 1983 |
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised … JR Tarn, N Howard-Tripp, DW Lendrem, X Mariette, A Saraux, ... The Lancet Rheumatology 1 (2), e85-e94, 2019 | 115 | 2019 |
Sleeping and vigilance in birds, II. An experimental study of the Barbary dove (Streptopelia risoria) DW Lendrem Animal Behaviour 32 (1), 243-248, 1984 | 100 | 1984 |
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines NH Tripp, J Tarn, A Natasari, C Gillespie, S Mitchell, KL Hackett, ... RMD open 2 (2), e000282, 2016 | 92 | 2016 |
Impaired functional status in primary Sjögren's syndrome KL Hackett, JL Newton, J Frith, C Elliott, D Lendrem, H Foggo, S Edgar, ... Arthritis care & research 64 (11), 1760-1764, 2012 | 91 | 2012 |
DOE (design of experiments) in development chemistry: Potential obstacles D Lendrem, M Owen, S Godbert Organic Process Research & Development 5 (3), 324-327, 2001 | 89 | 2001 |
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome JL Newton, J Frith, D Powell, K Hackett, K Wilton, S Bowman, E Price, ... Annals of the rheumatic diseases 71 (12), 1973-1979, 2012 | 71 | 2012 |
Why is it hard to terminate failing projects in pharmaceutical R&D? RW Peck, DW Lendrem, I Grant, BC Lendrem, JD Isaacs Nature reviews Drug discovery 14 (10), 663-664, 2015 | 65 | 2015 |
Modelling in behavioural ecology: an introductory text D Lendrem Springer Science & Business Media, 2012 | 61 | 2012 |
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy FAH Cooles, AE Anderson, DW Lendrem, J Norris, AG Pratt, CMU Hilkens, ... Journal of Allergy and Clinical Immunology 141 (1), 445-448. e4, 2018 | 52 | 2018 |
A transcriptional signature of fatigue derived from patients with primary Sjögren’s syndrome K James, S Al-Ali, J Tarn, SJ Cockell, CS Gillespie, V Hindmarsh, J Locke, ... PloS one 10 (12), e0143970, 2015 | 52 | 2015 |
CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in patients with untreated early arthritis: implications for causal gene identification N Thalayasingam, N Nair, AJ Skelton, J Massey, AE Anderson, AD Clark, ... Arthritis & Rheumatology 70 (3), 361-370, 2018 | 51 | 2018 |
Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study KF Baker, AJ Skelton, DW Lendrem, A Scadeng, B Thompson, AG Pratt, ... Journal of autoimmunity 105, 102298, 2019 | 49 | 2019 |
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically … MA Graham, S Senan, H Robin Jr, N Eckhardt, D Lendrem, J Hincks, ... Cancer chemotherapy and pharmacology 40, 1-10, 1997 | 49 | 1997 |